Identification of a novel variant c. 761C >T on ABO*B.01 gene in ABO glycosyltransferases associated with B weak phenotype
Vox Sanguinis · 2023
DOI: 10.1111/vox.13511 ↗Kurz gefasst
Fachartikel in der Zeitschrift Vox Sanguinis, 2023. Verfasst von Hang Lei und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: ABO Blood-Group System, Glycosyltransferases, Mutation, Missense. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 23 Literaturangaben. Gefördert von: National Natural Science Foundation of China, WeiGao Science Foundation of Chinese Society of Blood Transfusion.
Abstract (Originalsprache)
Background and Objectives ABO antigens are produced from H antigen by the activity of glycosyltransferase enzyme encoded by the ABO gene. Variants in the ABO gene can produce a weak ABO phenotype. In this study, we identify a novel ABO*BW allele and investigate the underlying mechanism leading to the B weak phenotype. Materials and Methods The ABO phenotype and genotype of the sample were determined using serological and direct DNA sequencing methods. We assessed the impact of the novel variant by three‐dimensional modelling to predict protein stability changes (ΔΔ G ), and carried out an in vitro expression assay. The total glycosyltransferase transfer capacity in the supernatant of transfected cells was also examined.
Results
Serological analysis confirmed the B weak phenotype in the subject, and gene sequencing identified a novel variant c.761C>T (p.A254V) on the ABO*B.01 allele, resulting in a BW‐var/O.01.02 genotype. In silico analysis suggested that the p.A254V variant on the B allele may reduce the stability of glycosyltransferase B (GTB), as indicated by the ΔΔ G values. In vitro expression studies showed that the variant p.A254V impaired H to B antigen conversion, although it did not affect the expression of GTB.
Conclusion
We identified a novel BW allele and demonstrated that the variant c.761C>T (p.A254V) can cause the B weak phenotype by reducing the stability of GTB.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Blood Transfusion Department, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Department of Blood Transfusion, Minhang Hospital, Fudan University, Shanghai, China.
- Blood Group Reference Laboratory, Shanghai Institute of Blood Transfusion, Shanghai Blood Center, Shanghai, China.
ORCID-Profile: Hang Lei, Xiaohong Cai
Förderung
- National Natural Science Foundation of China
- WeiGao Science Foundation of Chinese Society of Blood Transfusion
Zitieren
APA
Lei, H., Zhang, H., Guo, L., Xiang, D., Wang, X., Liu, X., & Cai, X. (2023). Identification of a novel variant c. 761C >T on ABO*B.01 gene in ABO glycosyltransferases associated with B weak phenotype. Vox Sanguinis. https://doi.org/10.1111/vox.13511
Vancouver
Lei H, Zhang H, Guo L, Xiang D, Wang X, Liu X, et al. Identification of a novel variant c. 761C >T on ABO*B.01 gene in ABO glycosyltransferases associated with B weak phenotype. Vox Sanguinis. 2023. doi:10.1111/vox.13511
BibTeX
@article{Lei2023,
author = {Lei, Hang and Zhang, Hui and Guo, Liujun and Xiang, Dong and Wang, Xuefeng and Liu, Xi and Cai, Xiaohong},
title = {Identification of a novel variant c. 761C >T on ABO*B.01 gene in ABO glycosyltransferases associated with B weak phenotype},
journal = {Vox Sanguinis},
year = {2023},
doi = {10.1111/vox.13511}
}
EUVIMED